Has Tara Lawlor, DO received payments from drug or device companies?

Yes. Drug and device makers reported $1,447 in general payments to Tara Lawlor, DO across 91 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tara Lawlor, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tara Lawlor, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tara Lawlor, DO

Dermatology · Reading, PANPI 1326088600

Payments from drug & device makers

$1,447in general payments, 2019–2025

Across 91 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$394
Johnson & Johnson$214
Incyte Corporation$188
Novartis$144
Almirall LLC$69
LEO Pharma Inc.$45
plus $393 from 16 others

What the payments were for

Food & beverage$1,34493%
Education$1037%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	43	$394
Johnson & Johnson	6	$214
Incyte Corporation	9	$188
Novartis	7	$144
Almirall LLC	2	$69
LEO Pharma Inc.	3	$45
Botanix SB Inc	2	$44
Sandoz	2	$43
Arcutis Biotherapeutics, Inc.	2	$42
Sun Pharmaceutical Industries Inc.	2	$38
Sanofi	1	$34
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$25
E.r. Squibb & Sons, L.L.C.	1	$21
GSK	1	$20
Helsinn Therapeutics (U.S.), Inc.	1	$18
Lilly USA, LLC	1	$17
Boehringer Ingelheim	1	$16
Amgen	1	$15
Galderma Laboratories, L.p.	1	$15
Dermavant Sciences, Inc.	1	$15
Journey Medical Corporation	1	$15
Verrica Pharmaceuticals Inc.	1	$14

How this compares

$1,447 in reported general payments places this provider in the 45th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$551,655

Medicare patients

1,159

Services billed

8,801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	114	$2,559
Fluorouracil	31	$1,978
Clobetasol Propionate	26	$1,430
Metronidazole	31	$1,420
Betamethasone Valerate	14	$1,214
Mupirocin	117	$1,118
ValacyclovirValacyclovir Hcl	47	$1,098
Triamcinolone Acetonide	74	$816
Betamethasone Dipropionate	17	$771
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	22	$560
Doxycycline Hyclate	12	$227
Hydrocortisone	27	$164

Paid to pharmacies, not to this prescriber.

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other dermatology in Reading